Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

被引:108
|
作者
Scalone, Luciana [1 ,2 ,3 ]
Ciampichini, Roberta [2 ]
Fagiuoli, Stefano [4 ]
Gardini, Ivan [5 ]
Fusco, Francesco [2 ]
Gaeta, Laura [4 ]
Del Prete, Anna [4 ]
Cesana, Giancarlo [1 ]
Mantovani, Lorenzo G. [2 ,6 ]
机构
[1] Univ Milano Bicocca, Res Ctr Publ Hlth, CESP, Milan, Italy
[2] CHARTA Fdn, Milan, Italy
[3] Fdn Charta, I-20122 Milan, Italy
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[5] Patients Org EpaC ONLUS, Milan, Italy
[6] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy
关键词
Health-related quality of life (HRQoL); Chronic hepatic diseases; EQ-5D-3L; EQ-5D-5L; Psychometric performance; QUALITY-OF-LIFE; LIVER-DISEASE; SPANISH VERSION; 5-LEVEL VERSION; 3-LEVEL SYSTEM; CANDIDATES; UTILITIES; VALIDITY;
D O I
10.1007/s11136-012-0318-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To assess the performance of the EQ-5D-5L version compared with the standard EQ-5D-3L in a clinical setting targeted at patients with chronic hepatic diseases (CHDs). We introduced the 5L descriptive system into a cost-of-illness study involving patients with different CHDs. The patients completed a questionnaire including the two versions of the EQ-5D, together with other questions related to their condition. We tested the feasibility, the level of inconsistency, the redistribution properties among consistent responses, the ceiling effect, the discriminative power, and the convergent validity of the 5L compared with the 3L system. A total of 1,088 valid patients were recruited: 62 % male, 19-89 (median = 59) years old. Patients had chronic hepatitis from HCV (31.8 %) or HBV infections (29.3 %) or other causes (7.8 %), 20.4 % had cirrhosis, 11.9 % underwent liver transplantation, and 7.8 % had hepatic carcinoma. Less than 1 % of EQ-5D-5L were returned blank, and 1.6 % or less of missing values were calculated on the dimensions of the partially completed questionnaires. The proportion and weight of inconsistent responses (i.e., 3L responses that were at least two levels away from the 5L responses) was 2.9 % and 1.2 on average, respectively. Regarding redistribution, 57-65 % of the patients answering level 2 with the 3L version redistributed their responses to levels 2 or 4 with the 5L version. A relative 7 % reduction of the ceiling effect was found. Furthermore, the absolute informativity increased but the relative informativity slightly decreased in every domain, and the convergent validity with the VAS improved. In a clinical setting involving CHD patients, the EQ-5D-5L was shown to be feasible and with promising levels of performance. Our findings suggest that the 5L performs better in at least some of the properties analyzed, and encourage further research to also test other psychometric properties of this new version of the EQ-5D.
引用
收藏
页码:1707 / 1716
页数:10
相关论文
共 50 条
  • [31] EQ-5D Brazilian population norms
    Santos, Marisa
    Monteiro, Andrea L.
    Santos, Braulio
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [32] What Determines the Shape of an EQ-5D Index Distribution?
    Parkin, David
    Devlin, Nancy
    Feng, Yan
    MEDICAL DECISION MAKING, 2016, 36 (08) : 941 - 951
  • [33] The EQ-5D as a measure of health outcomes
    Cabases, Juan M.
    GACETA SANITARIA, 2015, 29 (06) : 401 - 403
  • [34] EQ-5D-3L and EQ-5D-5L population norms for Thailand
    Kangwanrattanakul, Krittaphas
    Krageloh, Christian U.
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [35] Scale Characteristics and Mapping Accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in Patients with Rheumatoid Arthritis
    Wolfe, Frederick
    Michaud, Kaleb
    Wallenstein, Gene
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1615 - 1625
  • [36] Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing
    Juan Zhu
    Xin-Xin Yan
    Cheng-Cheng Liu
    Hong Wang
    Le Wang
    Su-Mei Cao
    Xian-Zhen Liao
    Yun-Feng Xi
    Yong Ji
    Lin Lei
    Hai-Fan Xiao
    Hai-Jing Guan
    Wen-Qiang Wei
    Min Dai
    Wanqing Chen
    Ju-Fang Shi
    Quality of Life Research, 2021, 30 : 841 - 854
  • [37] Testing for Differential Item Functioning within the EQ-5D
    Whynes, David K.
    Sprigg, Nikola
    Selby, James
    Berge, Eivind
    Bath, Philip M.
    MEDICAL DECISION MAKING, 2013, 33 (02) : 252 - 260
  • [38] EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
    Hawe, Emma
    McBride, Doreen
    Balp, Maria-Magdalena
    Tian, Haijun
    Halliday, Anna
    Stull, Donald E.
    PHARMACOECONOMICS, 2016, 34 (05) : 521 - 527
  • [39] Why Do Patients with Inflammatory Arthritis Often Score States "Worse than Death" on the EQ-5D? An Investigation of the EQ-5D Classification System
    Harrison, Mark J.
    Davies, Linda M.
    Bansback, Nick J.
    McCoy, Melanie J.
    Farragher, Tracey M.
    Verstappen, Suzanne M. M.
    Hassell, Andrew
    Symmons, Deborah P. M.
    VALUE IN HEALTH, 2009, 12 (06) : 1026 - 1034
  • [40] Clinimetrics: The EuroQol-5 Dimension (EQ-5D)
    Oliveira, Juliana S.
    Hayes, Alison
    JOURNAL OF PHYSIOTHERAPY, 2020, 66 (02) : 133 - 133